GENERATE BIOMEDICINES INC (GENB) Stock Income Statement
NASDAQ:GENB • US3709201004
Current stock price
12.47 USD
+0.02 (+0.16%)
At close:
12.4 USD
-0.07 (-0.56%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | ||||
|---|---|---|---|---|---|
| Revenue | 32.00M | 20.00M | |||
| Minority Interest Expense | 20.00M | 7.61M | |||
| Operating Expenses | 267.00M | 217.00M | |||
| Selling, General, and Administrative Expenses | 42.00M | 42.00M | |||
| Operating Income | -235.00M | -197.00M | |||
| Other Income/Expense | 12.00M | 16.00M | |||
| Income Before Taxes | -223.00M | -181.00M | |||
| Income Tax | 160.00K | 210.00K | |||
| Net Income | -250.00M | -214.00M | |||
| EBITDA | -222.00M | -182.00M | |||
| Per Share Data | |||||
| EPS Diluted Total Ops | -1.96 | -1.68 | |||
| Statistics | |||||
| Profit Margin | -781.25% | -1070.00% | |||
| Operating Profit Margin | -734.38% | -985.00% | |||
All data in USD